U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C5H5N5.ClH
Molecular Weight 171.588
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ADENINE HYDROCHLORIDE

SMILES

Cl.NC1=NC=NC2=C1N=CN2

InChI

InChIKey=UQVDQSWZQXDUJB-UHFFFAOYSA-N
InChI=1S/C5H5N5.ClH/c6-4-3-5(9-1-7-3)10-2-8-4;/h1-2H,(H3,6,7,8,9,10);1H

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/25797921 | https://www.ncbi.nlm.nih.gov/pubmed/9046330 | https://www.ncbi.nlm.nih.gov/pubmed/2165159 | https://www.ncbi.nlm.nih.gov/pubmed/27776394 | https://www.ncbi.nlm.nih.gov/pubmed/26243842

Adenine is a nucleobase (a purine derivative). Its derivatives have a variety of roles in biochemistry including cellular respiration, in the form of both the energy-rich adenosine triphosphate (ATP) and the cofactors nicotinamide adenine dinucleotide (NAD) and flavin adenine dinucleotide (FAD). It also has functions in protein synthesis and as a chemical component of DNA and RNA. The shape of adenine is complementary to either thymine in DNA or uracil in RNA

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
85.8 µM [Ki]
200.0 µM [IC50]
10.89 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
LEUKOTRAP WB SYSTEM

Approved Use

Indicated for collection of blood and preparation of red blood cells and plasma with pre-storage leukocyte reduction. Platelet concentrates are not intended to be made with this product.
Secondary
Unknown

Approved Use

Unknown
Secondary
Unknown

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
6.8 μM
27 μmol/kg single, oral
dose: 27 μmol/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
ADENINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
PubMed

PubMed

TitleDatePubMed
UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals.
2001
Ionization mechanism of oligonucleotides in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
2001
Mechanisms and modulation of intestinal epithelial repair.
2001 Feb
Renal interstitial adenosine metabolism during ischemia in dogs.
2001 Feb
Orexin A stimulates cortisol secretion from human adrenocortical cells through activation of the adenylate cyclase-dependent signaling cascade.
2001 Feb
RIZ, the retinoblastoma protein interacting zinc finger gene, is mutated in genetically unstable cancers of the pancreas, stomach, and colorectum.
2001 Feb
"Chemical preconditioning" by 3-nitropropionate reduces ischemia-reperfusion injury in cardiac-arrested rat lungs.
2001 Feb 15
Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717.
2001 Feb 15
Cytomegalovirus infection increases the expression and activity of ecto-ATPase (CD39) and ecto-5'nucleotidase (CD73) on endothelial cells.
2001 Feb 23
Adenine and guanine nucleotide-specific succinyl-CoA synthetases in the clonal beta-cell mitochondria: implications in the beta-cell high-energy phosphate metabolism in relation to physiological insulin secretion.
2001 Jan
Side chain-dependent binding of antitumor indoloquinoxaline derivatives to DNA: comparative spectroscopic and viscometric measurements.
2001 Jan
Molecular and biochemical characterization of a cytokinin oxidase from maize.
2001 Jan
Evolutionary optimization of metabolic pathways. Theoretical reconstruction of the stoichiometry of ATP and NADH producing systems.
2001 Jan
A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations.
2001 Jan
Development of cloned embryos from adult rabbit fibroblasts: effect of activation treatment and donor cell preparation.
2001 Jan
Oxidation of pyridine nucleotides during Fas- and ceramide-induced apoptosis in Jurkat cells: correlation with changes in mitochondria, glutathione depletion, intracellular acidification and caspase 3 activation.
2001 Jan 15
Regulation of protein degradation and protease expression by mannose in maize root tips. Pi sequestration by mannose may hinder the study of its signaling properties.
2001 Mar
Patents

Sample Use Guides

the daily dose of adenine is 10-60 mg/day
Route of Administration: Oral
NIH/3T3 cells were plated at a density of 2 × 106 cells and left untreated overnight, cultural media was exchanged and experimental plates were exposed to adenine (200 -1200 mkM) for 24 hr. Cells were counted at various concentration of adenine or AICAR with a hemocytometer after diluting the sample 1:1 with 0.4% trypan blue solution (Sigma-Aldrich, St. Louis, MO, USA). Alternatively, the cell cytotoxicity of the cells was monitored with XTT assay. 50 μL of XTT reagent was added and the plates were then incubated for 4 hr at 37 °C in the dark. The absorbance at 490 nm with a reference wavelength set at 690 nm using VersaMax ELISA microplate reader
Name Type Language
LEUCON
Preferred Name English
ADENINE HYDROCHLORIDE
WHO-DD  
Systematic Name English
6-AMINOPURINE HYDROCHLORIDE
Systematic Name English
9H-PURIN-6-AMINE, HYDROCHLORIDE (1:1)
Systematic Name English
Adenine hydrochloride [WHO-DD]
Common Name English
Code System Code Type Description
SMS_ID
100000077959
Created by admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
PRIMARY
DRUG BANK
DBSALT002225
Created by admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
PRIMARY
EVMPD
SUB12739MIG
Created by admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
PRIMARY
FDA UNII
364H11M7OD
Created by admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
PRIMARY
PUBCHEM
76219
Created by admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
PRIMARY
EPA CompTox
DTXSID10883907
Created by admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
PRIMARY
ECHA (EC/EINECS)
220-867-0
Created by admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
PRIMARY
CAS
2922-28-3
Created by admin on Mon Mar 31 18:57:19 GMT 2025 , Edited by admin on Mon Mar 31 18:57:19 GMT 2025
PRIMARY